Progyny director plans $312K stock sale in 2026

A Progyny director has filed a Rule 144 notice to sell 11,500 common shares following a stock option exercise.

Available on EDGAR 09/10/2026 - 01:58 PM EDT Accepted by SEC EDGAR 09/10/2026 - 01:58 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Progyny, Inc. (PGNY) is the issuer of common stock that director Kevin Gordon plans to sell under Rule 144. A notice covers the proposed sale of 11,500 shares of common stock, expected on September 10, 2026, following a stock option exercise for cash from the issuer. The filing lists Fidelity Brokerage Services LLC as the broker for the transaction and names NASDAQ as the securities exchange.

Key Figures

Shares to be sold: 11,500 shares Aggregate market value: $311,858.72 Proposed sale date: September 10, 2026

3 metrics

Shares to be sold 11,500 shares Common stock planned to be sold under Rule 144 by director Kevin Gordon

Aggregate market value $311,858.72 Aggregate market value for 11,500 Progyny common shares covered by the notice

Proposed sale date September 10, 2026 Date associated with the planned Rule 144 sale and option exercise for cash

Key Terms

Rule 144, stock option exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 09/10/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as attorney-in-fact for Kevin Gordon"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Progyny, Inc. (PGNY)?

The filing discloses that director Kevin Gordon plans to sell 11,500 shares of Progyny common stock under Rule 144, with the shares to be acquired via a stock option exercise for cash from the issuer and sold through Fidelity Brokerage Services LLC.

How many Progyny (PGNY) shares are covered by this Rule 144 notice?

The notice covers a proposed sale of 11,500 shares of Progyny, Inc. common stock. These shares are to be sold under Rule 144 after being acquired through a stock option exercise for cash from the issuer.

What is the aggregate market value of the Progyny (PGNY) shares in this Form 144?

The filing lists an aggregate market value of $311,858.72 for the 11,500 shares of Progyny common stock proposed to be sold under Rule 144, with the shares to be traded on NASDAQ.

When is the proposed sale date for the Progyny (PGNY) shares under this Form 144?

The Form 144 indicates a proposed transaction date of September 10, 2026 for the sale of 11,500 Progyny common shares, which are to be acquired via a stock option exercise for cash from the issuer.

Who is handling the brokerage for the Progyny (PGNY) Form 144 sale?

The brokerage for the proposed sale of 11,500 Progyny common shares is listed as Fidelity Brokerage Services LLC. The shares are expected to be sold on NASDAQ following a stock option exercise for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001218483
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Progyny, Inc.
SEC File Number	001-39100
Address of Issuer	1359 BROADWAY 2ND FLOOR NEW YORK NEW YORK 10018
Phone	212-888-3124
Name of Person for Whose Account the Securities are To Be Sold	GORDON KEVIN K
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11500	311858.72	76726798	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2026	Stock Option Exercise	Issuer			11500	09/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin Gordon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)